 |
| Image Source-Google | Image by- | technologynetworks |
Visual prosthetics are being evolved as a potentially precious resource for people with visual degradation. Only 3 visual prosthetic devices have received marketing approval inside the EU. Argus II, co-evolved on the University of Southern California (USC) Eye Institute and manufactured by Second Sight Medical Products Inc., became the first tool to have received advertising and marketing approval (CE Mark in Europe in 2011). Most different efforts remain investigational; the Retina Implant AG’s Alpha IMS gained a CE Mark July 2013 and is a giant development in decision. It isn’t always, however, FDA-authorized inside the US.